Use of Administrative Claims Data for Identifying Patients with Cirrhosis

Cited by (212)

Items 101–200 of 212

1. Accurate Identification of Patients with Cirrhosis and Its Complications in the Electronic Health Record
   Ali Khalifa, Jihad S. Obeid, Mathew J. Gregoski, Don C. Rockey · 2023 · Digestive Diseases and Sciences
2. Where you live matters: Area deprivation predicts poor survival and liver transplant waitlisting
   Bima J. Hasjim, Alexander A. Huang, Mitchell J. Paukner, Praneet Polineni, Alexandra Harris, Mohsen Mohammadi, Kiarri N. Kershaw, Therese Elaine Banea, Lisa B. VanWagner, Lihui Zhao et al. · 2024 · American Journal of Transplantation
3. Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV Infection
   Elliot B. Tapper, Neehar D. Parikh, Pamela K. Green, Kristin Berry, Akbar K. Waljee, Andrew M. Moon, George N. Ioannou · 2019 · Clinical Gastroenterology and Hepatology
4. The cirrhosis care Alberta (CCAB) protocol: implementing an evidence-based best practice order set for the management of liver cirrhosis - a hybrid type I effectiveness-implementation trial
   Michelle Carbonneau, Ejemai Eboreime, Ashley M. Hyde, Denise Lynn Campbell-Scherer, Peter Faris, Leah M Gramlich, Ross T. Tsuyuki, Stephen E. Congly, Abdel Aziz Shaheen, Matthew D Sadler et al. · 2020 · BMC Health Services Research
5. FIB ‐4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine‐Gray competing risk analysis
   Andrew D. Schreiner, Jingwen Zhang, William P. Moran, David Koch, Justin E. Marsden, Sherry Livingston, Patrick D. Mauldin, Mulugeta Gebregziabher · 2022 · Liver International
6. Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment
   Lamia Haque, David A. Fiellin, Janet P. Tate, Denise Ann Esserman, Debika Bhattacharya, Adeel Ajwad Butt, Stephen Crystal, Eva Jennifer Edelman, Adam J. Gordon, Joseph K. Lim et al. · 2022 · JAMA Network Open
7. Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients
   Mohammed J. Saeed, Margaret A A Olsen, William G. Powderly, Rachel M. Presti · 2016 · Journal of Clinical Gastroenterology
8. Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohort
   Vincent Lingzhi Chen, Amit G. Singal, Elliot B. Tapper, Neehar D. Parikh · 2020 · Liver International
9. Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study
   Robert J. Driver, Vinay Kumar Balachandrakumar, Anya J. Burton, Jessica E. Shearer, Amy Downing, Tim J. S. Cross, Eva J.A. Morris, Ian A.C. Rowe · 2019 · BMJ Open
10. Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis
    Fu‐Shun Yen, James Cheng‐Chung Wei, Lu‐Ting Chiu, Chih‐Cheng Hsu, Ming‐Chih Hou, Chii‐Min Hwu · 2020 · Liver International
11. Prevalence and Patterns of Opioid Use Before and After Liver Transplantation
    David C. Cron, Monica A. Tincopa, Jay Soong-Jin Lee, Akbar K. Waljee, Ali Hammoud, Chad M. Brummett, Jennifer F. Waljee, Michael J. Englesbe, Christopher J. Sonnenday · 2020 · Transplantation
12. Progression to cirrhosis is similar among all ages in nonalcoholic fatty liver disease, but liver-related events increase with age
    Matthew J. Miller, Emily Rose Harding-Theobald, Jacob V. DiBattista, Zhe Zhao, Karn Wijarnpreecha, Anna Suk-Fong Lok, Vincent Lingzhi Chen · 2023 · Hepatology Communications
13. Non‐selective beta‐blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infection
    Roula Sasso, Don C. Rockey · 2020 · Alimentary Pharmacology & Therapeutics
14. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy
    Daniel G. Whitney, Mary M. Schmidt, Heidi J. Haapala · 2020 · Journal of Managed Care & Specialty Pharmacy
15. Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial
    Amit G. Singal, Manasa Narasimman, Darine Daher, Sruthi Yekkaluri, Yan Liu, MinJae Lee, Vanessa Cerda, Aisha Khan, Karim Seif El Dahan, Jennifer R. Kramer et al. · 2024 · Gut
16. Quality of Care in the Cirrhotic Patient
    Michael L. Volk, Fasiha Kanwal · 2016 · Clinical and Translational Gastroenterology
17. Cirrhotic Patients on Mechanical Ventilation Have a Low Rate of Successful Extubation and Survival
    Roula Sasso, Steven D. Lauzon, Don C. Rockey · 2020 · Digestive Diseases and Sciences
18. Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
    Fu‐Shun Yen, Jung‐Nien Lai, James Cheng‐Chung Wei, Lu‐Ting Chiu, Chii‐Min Hwu, Ming‐Chih Hou, Chih‐Cheng Hsu · 2020 · PLoS ONE
19. Antiplatelet Medications Are Associated With Bleeding and Decompensation Events Among Patients With Cirrhosis
    Sarah R. Lieber, Yue Jiang, Andrew M. Moon, Alfred Sidney Barritt · 2021 · Journal of Clinical Gastroenterology
20. Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population‐based retrospective cohort study
    Amber Afzal, Brian F. Gage, Luo Suhong, Martin William Schoen, Kevin Korenblat, Kristen Marie Sanfilippo · 2022 · Journal of Thrombosis and Haemostasis
21. Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis
    Amit G. Singal, Yixing Chen, Shrihari Sridhar, Vikas Mittal, Hannah M. Fullington, Muzeeb Shaik, Akbar K. Waljee, Jasmin A. Tiro · 2021 · Clinical Gastroenterology and Hepatology
22. In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge
    Andrew M. Moon, Yue Jiang, Shari S. Rogal, Jasper Becker, Alfred Sidney Barritt · 2020 · PLoS ONE
23. Venous thromboembolism, chronic liver disease and anticoagulant choice: effectiveness and safety of direct oral anticoagulants versus warfarin
    Oluwadolapo D. Lawal, Herbert D. Aronow, Anne Lamont Hume, Fisayomi O. Shobayo, Kelly L. Matson, Marilyn McFarland Barbour, Yichi Zhang, Xuerong Wen · 2023 · Research and Practice in Thrombosis and Haemostasis
24. Missed and Delayed Diagnoses of Chronic Liver Disease in Primary Care Patients with Cirrhosis
    Kush M Patel, Jingwen Zhang, Justin E. Marsden, Chloe Bays, Patrick D. Mauldin, Andrew D. Schreiner · 2024 · Digestive Diseases and Sciences
25. A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States
    Kamesh Gupta, Bandhul Hans, Ahmad Hassan Khan, Syed Hamza Sohail, Devika Kapuria, Chris Chang · 2022 · World Journal of Hepatology
26. The confusion assessment method for the intensive care unit in patients with cirrhosis
    Eric S. Orman, Anthony J. Perkins, Marwan Ghabril, Babar Ali Khan, Naga Chalasani, Malaz A. Boustani · 2015 · Metabolic Brain Disease
27. The financial burden after liver transplantation is significant among commercially insured adults: A large US National Cohort
    Sarah R. Lieber, Yue Jiang, Alex R. Jones, Prajwal Gowda, Nneka N. Ufere, Madhukar S. Patel, Tami Gurley, Alvaro Noriega Ramirez, Van M. Ngo, Mary C. Olumesi et al. · 2023 · Liver Transplantation
28. Weight loss intention, dietary behaviors, and barriers to dietary change in veterans with lower extremity amputations
    Alyson J. Littman, Lynne Vernice McFarland, Mary Lou Thompson, Erin D. Bouldin, David E Arterburn, Barbara R. Majerczyk, Edward J. Boyko · 2014 · Disability and health journal
29. Infection in Hospitalized Cirrhosis Patients: Changing Epidemiology and Clinical Features
    Nida Choudry, Roula Sasso, Don C. Rockey · 2022 · The American Journal of the Medical Sciences
30. Validating new coding algorithms to improve identification of alcohol-associated and nonalcohol-associated cirrhosis hospitalizations in administrative databases
    Liam A. Swain, Jenny Godley, Mayur Brahmania, Juan G. Abraldeṣ, Karen L. Tang, Jennifer Flemming, Abdel Aziz Shaheen · 2024 · Hepatology Communications
31. Comparing the cost of cirrhosis to other common chronic diseases: A longitudinal study in a large national insurance database
    Filip Obradović, Dominic J. Vitello, Bima J. Hasjim, Joy E. Obayemi, Praneet Polineni, Michael W. Gmeiner, Eleena Koep, Aditya Jain, Federico Crippa, Andrés Duarte‐Rojo et al. · 2025 · Hepatology
32. Hospitalizations in Immigrants and Nonimmigrants Diagnosed With Chronic Hepatitis C Infection in Québec
    Rhiannon L. Kamstra, Laurent Azoulay, Russell John Steele, Marina B. Klein, Christina A. Greenaway · 2016 · Clinical Infectious Diseases
33. Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
    Fu‐Shun Yen, Ming‐Chih Hou, James Cheng‐Chung Wei, Ying‐Hsiu Shih, Chung Y. Hsu, Chih‐Cheng Hsu, Chii‐Min Hwu · 2022 · Frontiers in Pharmacology
34. Risk of seizures and status epilepticus in older patients with liver disease
    Ayham M. Alkhachroum, Clio Rubiños, Benjamin R. Kummer, Neal S. Parikh, Monica F. Chen, Abhinaba Chatterjee, Alexandra S. Reynolds, Alexander Eliot Merkler, Jan Claassen, Hooman Kamel · 2018 · Epilepsia
35. The Effect of Hospital Safety-Net Burden and Patient Ethnicity on In-Hospital Mortality Among Hospitalized Patients With Cirrhosis
    Robert J. Wong, Grishma Hirode · 2020 · Journal of Clinical Gastroenterology
36. Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis
    Backer Abdu, Shalaka Akolkar, Christopher Picking, Judith Boura, Marc S. Piper · 2020 · Digestive Diseases and Sciences
37. Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury
    Kavish Rohit Patidar, Mohammad Adibuzzaman, Mobasshir A. Naved, Dylan Rodriquez, James E. Slaven, Ananth Y. Grama, Archita P. Desai, Eduardo Vilar‐Gómez, Marwan Ghabril, Lauren Devore Nephew et al. · 2021 · Liver International
38. Artificial intelligence in the diagnosis of cirrhosis and portal hypertension
    Xiaoguo Li, Ning Kang, Xiaolong Qi, Yifei Huang · 2021 · Journal of Medical Ultrasonics
39. Predictors of Development of Hepatorenal Syndrome in Hospitalized Cirrhotic Patients with Acute Kidney Injury
    Roula Sasso, Ahmad Abou Yassine, Liliane S. Deeb · 2021 · Journal of Clinical Medicine
40. The burden of significant pain in the cirrhosis population: Risk factors, analgesic use, and impact on health care utilization and clinical outcomes
    Jessica B. Rubin, Rebecca Loeb, Cynthia L. Fenton, Chiung‐Yu Huang, Salomeh Keyhani, Karen H. Seal, Jennifer C. Lai · 2024 · Hepatology Communications
41. Disease trajectory and competing risks of patients with cirrhosis in the US
    Mohsen Mohammadi, Bima J. Hasjim, Salva Najib Balbale, Praneet Polineni, Alexander A. Huang, Mitchell J. Paukner, Therese Elaine Banea, O. Dentici, Dominic J. Vitello, Joy E. Obayemi et al. · 2025 · PLoS ONE
42. Impact of Hospitalization and Medication Switching on Post‐discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation
    Thanh Phuong Pham Nguyen, Yong Chen, Dylan P. Thibault, Charles E. Leonard, Sean Hennessy, Allison Wright Willis · 2020 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
43. Real-World Primary Care Data Comparing ALT and FIB-4 in Predicting Future Severe Liver Disease Outcomes
    Andrew D. Schreiner, Jingwen Zhang, William P. Moran, David Koch, Sherry Livingston, Chloe Bays, Justin E. Marsden, Patrick D. Mauldin, Mulugeta Gebregziabher · 2023 · Journal of General Internal Medicine
44. Benefits and harms of hepatocellular carcinoma screening outreach in patients with cirrhosis: a multicenter randomized clinical trial
    Amit G. Singal, Darine Daher, Manasa Narasimman, Sruthi Yekkaluri, Yan Liu, Vanessa Cerda, Chaitra Banala, Aisha Khan, MinJae Lee, Karim Seif El Dahan et al. · 2024 · JNCI Journal of the National Cancer Institute
45. The Use of Administrative Data to Investigate the Population Burden of Hepatic Encephalopathy
    Patricia Pringle Bloom, Elliot B. Tapper · 2020 · Journal of Clinical Medicine
46. Alcohol use disorder treatment and outcomes among hospitalized adults with alcoholic hepatitis
    Adam C. Winters, Folasade P. May, Yun Wang, Paul Shao, Liu Yang, Arpan Patel · 2021 · Drug and Alcohol Dependence Reports
47. Factor analysis of the biochemical markers related to liver cirrhosis
    Hyunjin Kim, Hae-Kag Lee, Jae-Hwan Cho · 2015 · Pakistan Journal of Medical Sciences
48. National trends of endoscopic retrograde cholangiopancreatography utilization and outcomes in decompensated cirrhosis
    Dhruv Mehta, Priti Poojary, Aparna Saha, Supreet Kaur, Shanti Patel, Lavneet Chawla, Arun Kumar, Priya K. Simoes, Deepthi Busayavalasa, Girish N. Nadkarni et al. · 2018 · Surgical Endoscopy
49. Association between cirrhosis and aneurysmal subarachnoid hemorrhage
    Neal S. Parikh, Alexander Eliot Merkler, Arun B. Jesudian, Hooman Kamel · 2018 · Annals of Clinical and Translational Neurology
50. Association Between End-Stage Liver Disease and Incident Heart Failure in an Integrated Health System
    Sarah E. Chuzi, Yoshihiro Tanaka, Avni A. Bavishi, Matthew Bruce, Lisa B. VanWagner, Jane E. Wilcox, Faraz S. Ahmad, Daniela P. Ladner, Tara C. Lagu, Sadiya S. Khan · 2023 · Journal of General Internal Medicine
51. Sodium-Glucose Cotransporter2 inhibitors and associated Liver-Related outcomes in diabetes patients
    Fu‐Shun Yen, James Cheng‐Chung Wei, Chen Wang, Ming‐Chih Hou, Teng‐Shun Yu, Yuhan Huang, Chii‐Min Hwu, Chih-Cheng Hsu · 2025 · Diabetes Research and Clinical Practice
52. SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis
    Mu‐Chi Chung, Tung‐Min Yu, Laing-You Wu, Ming-Ju Wu, Jeng‐Jer Shieh, Chi‐Jung Chung · 2026 · JAMA Network Open
53. Trends and outcomes of peptic ulcer disease in patients with cirrhosis
    Harshil Shah, Tsujung Yang, Ivan Wudexi, Shantanu Solanki, Shakumar Patel, Don Rajan, Aaron Rodas, Mousa Dajjani, Raja Chandra Chakinala, Priyal Shah et al. · 2020 · Postgraduate Medicine
54. 5-year risk of “adult-onset” chronic diseases during childhood and adolescent transitioning for individuals with cerebral palsy
    Daniel G. Whitney · 2022 · Preventive Medicine Reports
55. Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study
    Juan J. Gonzalez, Jennifer N. Dziwis, Yuval A. Patel, Elliot B. Tapper · 2022 · Digestive Diseases and Sciences
56. In‐hospital outcomes of transcatheter versus surgical mitral valve repair in patients with chronic liver disease
    Khalid Sawalha, Kamesh Gupta, Anis John Kadado, Mohammed Abozenah, Ayman Battisha, Colby Salerno, Ahmad Khan, Ashequl M. Islam · 2021 · International Journal of Clinical Practice
57. Diagnostic Value of Hepatic Vein Ultrasound in Early Detection of Liver Cirrhosis
    Hadi Zare Marzouni, Behrooz Davachi, Mahdi Rezazadeh, Mahmoud Salehi Milani, Sedighe Matinfard · 2018 · Galen Medical Journal
58. Sodium‐Glucose Cotransporter 2 Inhibitors Use in Patients With Liver Cirrhosis
    Fu‐Shun Yen, Ming‐Chih Hou, James Cheng‐Chung Wei, Yuhan Huang, Ying‐Hsiu Shih, Chun‐Wei Pan, Sing-Ting Wang, Chii‐Min Hwu, Chih‐Cheng Hsu · 2025 · Diabetes/Metabolism Research and Reviews
59. Prediction of long-term survival among patients with cirrhosis using time-varying models
    David Seth Goldberg, Yalda Zarnegarnia · 2023 · Hepatology Communications
60. Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data
    Kiyotaka Yamazaki, Dendy S. Macaulay, Yan Song, Yuri Sánchez González · 2019 · Infectious Diseases and Therapy
61. Development of a national Department of Veterans Affairs mortality risk prediction model among patients with cirrhosis
    Jejo Koola, Samuel B. Ho, Guanhua Chen, Amy M. Perkins, Aize Cao, Sharon E. Davis, Michael Edwin Matheny · 2019 · BMJ Open Gastroenterology
62. MELD–Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis
    Zachary P. Fricker, V V Pavan Kedar Mukthinuthalapati, Samuel A. Akinyeye, Naga Chalasani, Bashar M. Attar, Maya Balakrishnan, Marwan Ghabril, Michelle T. Long · 2020 · Digestive Diseases and Sciences
63. FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care
    Andrew D. Schreiner, Jingwen Zhang, William P. Moran, David Koch, Justin E. Marsden, Sherry Livingston, Chloe Bays, Patrick D. Mauldin, Mulugeta Gebregziabher · 2023 · Journal of Clinical Gastroenterology
64. Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Cirrhosis
    Tien‐Shin Chou, Yuan Lin, Ming‐Lung Tsai, Chin-Ju Tseng, Jhih-Wei Dai, Ning‐I Yang, Chih‐Lang Lin, Liwei Chen, Ming‐Jui Hung, Tien‐Hsing Chen · 2024 · Journal of Clinical Gastroenterology
65. Development and validation of a case definition to estimate the prevalence and incidence of cirrhosis in pan-Canadian primary care databases
    Nabiha Faisal, Leanne Kosowan, Hasan Zafari, Farhana H. Zulkernine, Lisa Marie Lix, Alyson L Mahar, Harminder Singh, Eberhard L. Renner, Alexander G. Singer · 2023 · Canadian Liver Journal
66. Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis
    Jaimin Patel, Adam Charles Yopp, Akbar K. Waljee, Amit G. Singal · 2015 · Journal of Clinical Gastroenterology
67. Temporal trends of cirrhosis associated conditions
    Tomoki Sempokuya, Guangxiang Zhang, Kazuma Nakagawa · 2019 · World Journal of Hepatology
68. Trends and outcomes of mechanically ventilated cirrhotic patients in the United States from 2005–2014
    Kyle Cheung, Jonathan F. Mailman, Jennifer Crawford, Constantine Jason Karvellas, Eric J. Sy · 2021 · Journal of the Intensive Care Society
69. Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease
    Joseph A. Moore, William H. Wheless, Jingwen Zhang, Justin E. Marsden, Patrick D. Mauldin, William P. Moran, Andrew D. Schreiner · 2023 · Digestive Diseases and Sciences
70. Diagnostic Performance of the ICD-10 Code K76.82 for Hepatic Encephalopathy in Patients With Cirrhosis
    Nazlı Begüm Öztürk, Laith H. Jamil, Elliot B. Tapper · 2023 · The American Journal of Gastroenterology
71. Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis
    Xiaowen Zhang, Ka Shing Cheung, Lung‐Yi Mak, K. C. B. Tan, Annie W.C. Kung, Ian Chi Kei Wong, Ching‐Lung Cheung · 2024 · The Journal of Clinical Endocrinology & Metabolism
72. A Machine Learning Algorithm Avoids Unnecessary Paracentesis for Exclusion of SBP in Cirrhosis in Resource-limited Settings
    Scott G. Silvey, Nilang Patel, Jinze Liu, Asiya Tafader, Mahum Nadeem, Galvin Dhaliwal, Jacqueline G. O’Leary, Heather M. Patton, Timothy R.M. Morgan, Shari S. Rogal et al. · 2024 · Clinical Gastroenterology and Hepatology
73. Burden of illness for patients with primary biliary cholangitis: an observational study of clinical characteristics and healthcare resource utilization
    Robert Gareth Gish, Joanna P. MacEwan, Alina Levine, Dannielle S. Lebovitch, Leona Bessonova, Darren Wheeler, Radhika Nair, Alan Bonder · 2025 · Journal of Comparative Effectiveness Research
74. Use of machine learning for early prediction of short-term mortality in veterans with metabolic dysfunction-associated steatotic liver disease
    Lewis J. Frey, Michael Fuchs, Ralph C Ward, Mulugeta Gebregziabher, Ahmad Basil Nasir, Yamini Natarajan, Andrew D. Schreiner, Don C. Rockey, Wing‐Kin Syn · 2025 · PLoS ONE
75. A machine learning approach to non-invasive prediction of hepatic decompensation in compensated advanced chronic liver disease: The CIRI model
    Georg Kramer, Anders Hildeman, Caterina Tozzi, Roza Maghsood, Vinusha Kalatharan, Hyewon Nina Koo, K Jastrzębska, Nils Svangård, Claire Donoghue, Benedikt Simbrunner et al. · 2026 · Journal of Hepatology
76. Hepatocellular Carcinoma Surveillance among Individuals with Cirrhosis: Trends by Payer, Etiology, and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010–2018
    Christine D. Hsu, Louise M. Henderson, Bradford E. Jackson, Christopher D. Baggett, Michele Jönsson Funk, Andrew F. Olshan, Parul Gupta, Alfred Sidney Barritt, Hanna Kelly Sanoff, Stephanie B. Wheeler et al. · 2023 · Cancer Epidemiology Biomarkers & Prevention
77. Outcomes among inpatients with cirrhosis and Clostridioides difficile infection in the modern era: results from an analysis of the National Inpatient Sample
    Sentia Iriana · 2021 · Annals of Gastroenterology
78. Patterns of gastroenterology specialty referral for primary care patients with metabolic dysfunction-associated steatotic liver disease
    John F.G. Bobo, Brad A. Keith, Justin E. Marsden, Jingwen Zhang, Andrew D. Schreiner · 2024 · The American Journal of the Medical Sciences
79. Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis
    Robert M. Wilechansky, Prasanna K. Challa, Xijing Han, Xinwei Hua, Alisa Knodle Manning, Kathleen E. Corey, Raymond T. Chung, Wei Zheng, Andrew Tan Chan, Tracey G. Simon · 2025 · Cancer Prevention Research
80. Validation of ICD‐10 Consensus Code Set for Cirrhosis Detection Using Electronic Health Records in an Asian Population
    Jason Pik-Eu Chang, Hong‐Yi Lin, Pooi‐Ling Loi, Jeanette Ng, Marianne De Roza, Rahul Kumar, Hiang Keat Tan, Chanda Kendra Ho, Wei‐Quan Teo, Amber Hwa Hwa Chung et al. · 2025 · JGH Open
81. COVID-19 Pandemic–Related Disruptions in Routine Cirrhosis Care and Associated Clinical Outcomes among San Francisco Bay Area Veterans
    Jessica B. Rubin, Rebecca Loeb, Alexander Monto, Robert J. Wong, Ramsey C Cheung, Steven L. Batki, Michael Joshua Ostacher, Hui Shen, Katherine J. Hoggatt, Derek D. Satre et al. · 2025 · Gastro Hep Advances
82. Identifying patients with diagnosed cirrhosis in administrative health databases: a validation study
    Nabiha Faisal, Lisa Marie Lix, Randy Walld, Alexander G. Singer, Eberhard L. Renner, Harminder Singh, Leanne Kosowan, Alyson L Mahar · 2024 · Canadian Liver Journal
83. In-Hospital Outcomes and 30-Day Readmission Rate After Transcatheter and Surgical Aortic Valve Replacement in Liver Cirrhosis: A Contemporary Propensity-Matched Analysis
    Abhinav Aggarwal, Sun-Joo Jang, Swarnima Vardhan, Fabrício Malaguez Webber, Md. Mashiul Alam, Madhurima Vardhan, Gilead I. Lancaster, Yousif Ahmad, Amit N. Vora, STUART W. ZARICH et al. · 2024 · Structural Heart
84. Shock Index, Modified Shock Index and MELD as Predictors of Mortality for Critically Ill Patients With Liver Disease
    Bachar Hamade, Raghavan Murugan, Elijah Z. Lovelace, Melissa I. Saul, David T. Huang, Ali H. Al-Khafaji · 2021 · Journal of Intensive Care Medicine
85. Letter to Editor: Using Proper Methods to Identify Patients With Cirrhosis in Administrative Databases Is Crucial to Correctly Predict Outcomes
    Abdel Aziz Shaheen, Mark G. Swain · 2018 · Hepatology
86. Etiology of cirrhosis is associated with risk of hepatic decompensation and hepatocellular carcinoma
    Michelle Ng, Olgert Bardhi, Krystal Lai, Eden Koo, Sruthi Yekkaluri, Kevin Bass, Guruveer S. Bhamra, Pojsakorn Danpanichkul, Lisa Quirk, Ju Dong Yang et al. · 2025 · BMC Gastroenterology
87. Albuminuria and Metabolic Dysfunction-Associated Steatotic Liver Disease with Advanced Fibrosis in Primary Care
    Jingwen Zhang, Ahmed Mohamed, Justin E. Marsden, Chloe Bays, Andrew D. Schreiner · 2025 · Metabolic Syndrome and Related Disorders
88. Accurately identifying cirrhosis and its complications to create the novel statewide Indiana digital cirrhosis registry
    Archita P. Desai, Hani Shamseddeen, Lauren R. Lembcke, Siu Lui Hui, Lauren Devore Nephew, Marwan Ghabril, Eric S. Orman, Naga Chalasani · 2026 · Scientific Reports
89. Association between statins and chronic liver disease progression: A retrospective cohort study
    Nicholas P. Smith, Andrew D. Schreiner, Jingwen Zhang, Justin E. Marsden, Mulugeta Gebregziabher, David Koch · 2026 · Clinics and Research in Hepatology and Gastroenterology
90. Risk Estimates of Five Adverse Outcomes Following Hip and Spine Surgery Among Children with Cerebral Palsy to Inform Peri-operative Care
    Daniel G. Whitney, Tania D. Strout, Judith A. Vessey, Rachel L. DiFazio · 2025 · Journal of the Pediatric Orthopaedic Society of North America
91. Transcatheter Mitral Valve Implantation In Patients With Chronic Kidney Disease
    Ayman Elbadawi, Mahmoud Abdelghany, Alexander Dang, Mohamed A. Omer, Awad I. Javaid, Mennallah Eid, Waleed T. Kayani, David Paniagua, Hani M. Jneid · 2022 · The American Journal of Cardiology
92. Factors of Development of Hepatorenal Syndrome in Patients with Liver Cirrhosis of Viral Etiology
    Sanokulova Sitora Avazovna · 2023 · Texas Journal of Medical Science
93. Adverse Drug Events and Renal Function
    Matthew A. Weir · 2013 · Scholarship@Western (Western University)
94. Delivering Quality Care to Patients with Cirrhosis: A Practical Guide for Clinicians
    Michael L. Volk, Fasiha Kanwal · 2015 · Springer eBooks
95. The relationship between a cirrhosis‐specific comorbidity scoring system and healthcare utilization patterns
    Ankur A. Dashputre, Branden D. Nemecek, Khalid M. Kamal, Jordan R. Covvey · 2018 · Journal of Gastroenterology and Hepatology
96. Short-Term Incidence of Sequelae of HCV Infection Among Medicaid Beneficiaries in Oregon
    Kazuaki Jindai, Courtney Crawford, Ann R Thomas · 2018 · Public Health Reports
97. Factors Related to Development of Pancreatic Adenocarcinoma in Patients With Chronic Pancreatitis on Long-term Follow-up: A Database Study
    Shashank Garg, Houssam E. Mardini · 2019 · The Permanente Journal
98. Modest performance of risk-prediction models for anticoagulant-related bleeding in patients with chronic liver disease
    Amber Afzal, Brian F. Gage, Luo Suhong, Martin William Schoen, Kristen Marie Sanfilippo · 2024 · Thrombosis Research
99. Additional file 1 of Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
    Fu‐Shun Yen, Ming‐Chih Hou, James Cheng‐Chung Wei, Ying‐Hsiu Shih, Chii‐Min Hwu, Chih‐Cheng Hsu · 2024 · Figshare
100. Predictors of Non-Variceal Hemorrhage in a National Cohort of Patients With Chronic Liver Disease
     Amber Afzal, Preethi Kesavan, Luo Suhong, Brian F. Gage, Kevin Korenblat, Martin William Schoen, Kristen Marie Sanfilippo · 2024 · Journal of Hematology